Due to the limited availability of repeated tissue biopsies, the proteomics and phosphoproteomics analysis of cancer cells with in vitro treatment of EGFR-TKI has been widely performed for the discovery of therapeutic targets and biomarkers. Here, EGFR is linked to cancer.